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Using Automated Glycan Assembly (AGA) for the Practical 
Synthesis of Heparan Sulfate Oligosaccharide Precursors
Darshita Budhadev a, Karinna Saxby a, Julia Walton a, Gideon Daviesa, Peter C. Tylerb, Ralf 
Schwörer*b and Martin A. Fascione*a
Herein we report synthesis of complex heparan sulfate 
oligosaccharide precursors by automated glycan assembly using 
disaccharide donor building blocks. Rapid access to a 
hexasaccharide was achieved through iterative solid phase 
glycosylations on a photolabile resin using the GlyconeerTM, an 
automated oligosaccharide synthesiser, followed by 
photochemical cleavage and glycan purification using simple flash 
column chromatography.
Heparan sulfate (HS) is a strongly anionic linear polysaccharide 
belonging to the glycosaminoglycan (GAG) family of 
macromolecules. HS chains are synthesized in the Golgi 
apparatus1 and comprise of a repeating N-acetyl glucosamine 
(GlcN)- D-glucuronic acid (GlcA) disaccharide unit. 
Modifications in the synthesis of HS chains include N-
deacetylation/N-sulfation of GlcN residues; epimerization of 
GlcA to L-iduronic acid (IdoA); sulfation at the 2-O position of 
IdoA and sulfation at the 6-O and 3-O positions of GlcN.2 
Owing to the high content of charged groups in HS, many 
proteins bind to HS through electrostatic interactions.3 HS 
chains can also be covalently attached to a core protein 
forming glycoproteins, known as Heparan Sulfate 
Proteoglycans (HSPGs). The functional role of the many forms 
of HS in different biological processes has been extensively 
studied4 particularly in growth factor mediated signalling,5 
chemotaxis,6, 7 and as a protein component of the extracellular 
matrix (ECM),8 where HSPGs are essential for maintaining the 
integrity of the ECM and basement membrane (BM) and 
modulating cell mobility.3
In vivo experiments9, 10 have also highlighted the 
interaction of HS and heparin (a HS analogue with higher 
degree of sulfation) with '$F peptide :F; plaques 
whose aggregation and deposition in brain parenchyma11 is a 
histopathological hallmark of Alzheimers disease (AD). These 
aggregates are formed of F peptides 40-42 amino acids long 
which are products of sequential cleavage of the 
transmembrane protein amyloid F precursor protein (APP) by 
F$ :F$ APP cleaving enzyme 1: BACE1) and I$
secretase.12 Although HS has been observed to co-deposit in 
F plaques, several studies have reported that HS 
oligosaccharides 1 of varying lengths,13, 14 can also modulate 
the activity of BACE1, whereby HS chains bind at or near the 
active site of BACE1 and prevent its access to the protein APP 
(Figure 1).15 However, despite success in establishing the 
interactions between HS and F peptides and BACE1, the 
heterogeneity of HS glycans purified from natural sources16 
has limited their utility for determining detailed structure-
activity relationships. Thus the synthesis of pure and 
homogeneous HS oligosaccharides is crucial for facilitating 
further biological studies. To date, the synthesis of HS 
oligosaccharides has been executed via chemoenzymatic,17-20 
solution-phase21-25 and solid-phase approaches,26 relying on 
many manual operations. But recently, automated glycan 
assembly (AGA)27, 28 has emerged as a powerful tool for the 
facile synthesis of biologically important carbohydrate 
libraries;29 including sulfated oligosaccharides and their 
protected precursors. 30-32  Herein we report an iterative 
automated solid-phase synthesis of HS oligosaccharide 
precursors using the GlyconeerTM,33 an automated 
oligosaccharide synthesizer, which can provide rapid access to 
oligosaccharides via AGA. 
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Figure 1: Cartoon illustration of the inhibition of BACE1 by HS chains. HS is depicted in 
simplified form 1 which may vary greatly in length (n can reach 125), and the 
oligosaccharide 2, targeted as proof of principle which is a precursor to a HS 
hexasaccharide.
As a proof of principle and because BACE1 inhibition was 
previously reported with a similar length oligosaccharide,13 we 
targeted the synthesis of a HS hexasaccharide precursor 2 with 
an orthogonal protecting group pattern. Specifically, the 
presence of the chloroacetate group at the O-6 position in the 
glucose moiety enables introduction of glucuronic acid 
through suitable deprotection and oxidation, whilst the azido 
group in the GlcN sugar can also be processed into the N-
acetamido group post glycosylation (Figure 1).14 We opted to 
utilise the disaccharide trichloroacetimidate (TCA) building 
block 3 as a donor in the GlyconeerTM to access the target 
hexasaccharide (Figure 2), firstly because the challenging J$
glycosidic linkage required between GlcN and GlcA in the final 
product was already in place14 and secondly, we anticipated 
that the benzoyl ester group at O-2 of GlcA would direct 
glycosylation following TCA activation in a stereoselective 
manner, ensuring only the formation of F$(' linkages 
during AGA. The O-4 position of the GlcN is also masked with a 
temporary orthogonal Fmoc protecting group which is suitable 
for deprotection on resin, prior to the anticipated elongation 
of the oligosaccharide through repetitive glycosylation using 
the disaccharide building block. For chain termination and to 
aid downstream purification, we designed building block 4 
containing a semi-permanent benzyl group at O-4 in place of 
Fmoc for the final glycosylation.
The disaccharide 3 was first synthesized in solution by the 
glycosylation between glucopyranoside donor (SI1) and the 
acceptor (SI2) in 71% yield following a reported method (See 
supporting information, Scheme S1).14 The p-methoxyphenyl 
group of the product was hydrolysed by ceric ammonium 
nitrate, followed by TCA installation.34 This TCA donor proved 
stable enough to be used as a building block on the 
GlyconeerTM and was chosen as its glycosylation had previously 
been optimised in solution.14 Additionally the donor provided a 
facile method for recycling excess donor hydrolysed during 
automated synthesis, through reinstallation of the TCA group 
directly from the hemiacetal 5, thus increasing the efficiency of 
the methodology. Notably, the entire synthesizer is kept under 
argon atmosphere to ensure complete exclusion of water; 
thereby minimizing any hydrolysis of the activated building 
blocks prior to delivery into the reaction vessel. Merrifield 
resin functionalised with a photolabile nitrobenzyl ether-based 
linker 7 (loading 0.40 mmol g-1) was chosen as a solid support 
for the assembly of the oligosaccharide, due to its stability in 
both acidic and basic solutions.35 
The synthesis of the oligosaccharide briefly includes 
iterative glycosylation of the resin and the building blocks 
followed by Fmoc deprotection and acid wash cycles in the 
GlyconeerTM. The desired length oligosaccharide was then 
cleaved from the resin photochemically prior to purification 
(Figure 2). Glycosylation of the resin with the disaccharide 
building block 3 commenced with a preprogrammed 
glycosylation-deprotection module (see supporting 
information Table S1) using trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) as the activating agent, 
followed by 5% piperidine in DMF as the Fmoc deprotecting 
solution. Optimisation of the first glycosylation module 
(attachment to the solid support) revealed that using 10 equiv. 
of donor building block 3 in the first cycle afforded higher 
conversions (75%) than two-cycles using 5 equiv. of donor 
(68%), or two-cycles using 3.5 equiv. of donor (43%). To 
maximise attachment of the sugar onto the resin we therefore 
opted to use 10 equiv. of donor 3 in the first cycle followed by 
a further 5 equiv. of donor in a second cycle. Resin loading was 
calculated following glycosylation, by cleaving a small portion 
of the resin and performing UV-based DBU-Fmoc assay36 
(which measures the amount of dibenzofulvene adduct 
released after Fmoc deprotection in solution). A washing step 
with Lewis acid (TMSOTf in dry CH2Cl2 at -30 °C for 1 min) was 
also introduced before each glycosylation module to ensure 
removal of any residual base from the previous deprotection 
step. 
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      Once the glycosylation conditions for the TCA disaccharide 
donors were standardised, the AGA of hexasaccharide 2 was 
achieved via iterative glycosylations using a further 
glycosylation-deprotection module (see Supporting 
Information, Module 2, Section 3). After completion of each 
synthetic cycle, total removal of Fmoc group from the resin-
bound glycan was monitored by measuring the UV signal 
through an in-line UV detector. The oligosaccharide was 
cleaved from the photolabile resin using an in-house 
photoreactor consisting of a mercury lamp of 400 W fitted 
with FEP tubing and connection to a cooling tap.37 Specifically 
the resin containing the glycan was suspended in CH2Cl2 and 
subsequently passed through a sample injector to the tubing 
surrounding the mercury lamp before filtration and 
concentration of the filtrate in vacuo. The crude protected 
glycan could then be analysed rapidly through MALDI-TOF MS. 
Although some target hexasaccharide was observed by MALDI-
TOF MS after three iterative glycosylations, the major product 
was the tetrasaccharide, a deletion sequence, which are 
common in solid phase synthesis and often result from an 
incomplete or unsuccessful coupling reaction during the 
programmed cycle. Therefore, in order to maximize the yield 
of hexasaccharide, four consecutive glycosylations were 
performed to account for the anticipated inefficiencies in the 
solid-phase glycosylation, and convert any tetrasaccharide 
deletion sequence into the hexasaccharide. Following crude 
product analysis, on this occasion, the hexasaccharide 2 was 
formed as the major product, with only a small amount of 
tetrasaccharide by-product (Figure S3 and S4). Although 
improved capping procedures have recently been reported to 
minimise such deletion sequence formation,38 we opted not to 
use capping  to ensure the minimum reaction time per cycle. 
Here, the use of a disaccharide building block was especially 
advantageous as deletion sequences were more disparate in 
size and polarity (tetra vs hexasaccharide) than would have 
been observed using monosaccharide building blocks. This 
facilitated the purification of the final hexasaccharide from any 
deletion sequences in 30% overall yield on a 15 mg scale, using 
only readily accessible silica gel column chromatography. 
Importantly the use of disaccharide building block strategy 
obviated the requirement for a highly optimised, costly and 
low yielding preparative HPLC purification, as has commonly 
been utilised following AGA.
A comparison to the synthesis of a similar hexasaccharide 
performed in solution using identical donor building blocks,14 
reveals that the automated synthesis reported here compares 
Figure 2: Schematic illustration of automated glycan assembly of hexasaccharide 2, highlighting the individual steps of glycosylation and deprotection which are performed in a 
repetitive cycle on the Glyconeer, followed by photochemical resin cleavage in a UV flow reactor, flash column chromatography purification, and TCA  donor recycling.
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favourably in terms of overall yield, but is far more time and 
resource efficient, taking less than a quarter of the time and 
requiring only one purification step as opposed to at least four 
in solution. Also, the excess hydrolysed donor 5 formed 
throughout the synthesis was automatically collected in the 
fraction collector, and could be subsequently recycled back 
into the TCA donor in solution. At the 0.02 mmol scale (50 mg 
resin, 0.40 mmol g-1 loading) employed here, 1.02 g of TCA 
donor was required for the complete hexasaccharide 
synthesis, but 657 mg of hemicacetal 5 was recovered which 
was then subjected to TCA reinstallation, with an overall donor 
recycling efficiency of ~60%. 
Finally, 1D and 2D NMR (Figure 3) corroborated the 
presence of 3 J$ and 3 F$ anomeric protons as expected from 
the final product. In total, desired HS hexasaccharide precursor 
2 was synthesized in 6 hours from the stable, scalable 
disaccharide donors, highlighting the potential of the 
GlyconeerTM to deliver rapid access to HS precursors, which 
can then be differentially sulfated and subjected to global 
deprotection as and when required. 
Figure 3: A) 1H NMR of pure hexasaccharide 2 and B) 1H-13C HSQC expansion of the 
anomeric region, highlighting the presence of three -anomeric linkages, and three -
anomeric linkages.
Conclusions
In conclusion, the automated synthesis of an orthogonally 
protected HS hexasaccharide precursor was achieved 
efficiently using the GlyconeerTM, providing scope to further 
explore the therapeutic role of HS in Alzheimers disease in 
greater molecular detail in the future. The cleavage of the 
oligosaccharide from the solid support was demonstrated 
using an in-house photoreactor, enabling practical analysis of 
the crude oligosaccharide in solution. The use of flash 
chromatography enabled a convenient practical purification of 
the target glycan without the need for preparative HPLC, 
removing deletion sequences in the process. Although by-
products such as deletion sequences formed in AGA can be 
reduced using capping procedures, the requirement for four 
iterative glycosylations to achieve three glycosidic linkages in 
this example highlights that further optimisation of 
glycosylation procedures in automated synthesis is still 
essential and represents a key area for exploration by 
synthetic carbohydrate chemists. 19, 33
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